Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer

The evaluation of PD‐L1 expression alone has limitations in predicting clinical outcome in immune‐checkpoint inhibitors (ICI). This study aimed to evaluate the predictive and prognostic effects of the presence of various immune cells in pretreatment tissue samples and to identify determinants associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ku, Bo Mi, Kim, Youjin, Lee, Kyoung Young, Kim, Sang‐Yeob, Sun, Jong‐Mu, Lee, Se‐Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung‐Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Tumor immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248238/
https://www.ncbi.nlm.nih.gov/pubmed/33506525
http://dx.doi.org/10.1002/eji.202048966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248238/
https://www.ncbi.nlm.nih.gov/pubmed/33506525
http://dx.doi.org/10.1002/eji.202048966

Ejemplares similares